Lyra Therapeutics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Maria Palasis
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 32.7% |
| CEO tenure | 9.3yrs |
| CEO ownership | n/a |
| Management average tenure | 2.2yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
Will Lyra Therapeutics (NASDAQ:LYRA) Spend Its Cash Wisely?
Jan 25
We Think Lyra Therapeutics (NASDAQ:LYRA) Needs To Drive Business Growth Carefully
Sep 10Is Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Deliver On Growth Plans?
Mar 12Lyra Therapeutics appoints Nieman as Chief Medical Officer
Jul 05Lyra Therapeutics: Progress In The Clinic
May 18A First Look At Lyra Therapeutics
Apr 21Is Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Deliver On Growth Plans?
Mar 30Is Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Invest In Growth?
Dec 14We Think Lyra Therapeutics (NASDAQ:LYRA) Can Afford To Drive Business Growth
Aug 28We're Not Very Worried About Lyra Therapeutics' (NASDAQ:LYRA) Cash Burn Rate
May 04How Many Lyra Therapeutics, Inc. (NASDAQ:LYRA) Shares Do Institutions Own?
Mar 05Companies Like Lyra Therapeutics (NASDAQ:LYRA) Are In A Position To Invest In Growth
Jan 11
Lyra Therapeutics down 19% underwhelming data from lead program
Dec 07Lyra Therapeutics: An Intriguing Risk/Reward Proposition Tackling Chronic Rhinosinusitis
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$583k | -US$63m |
| Sep 30 2023 | n/a | n/a | -US$62m |
| Jun 30 2023 | n/a | n/a | -US$61m |
| Mar 31 2023 | n/a | n/a | -US$60m |
| Dec 31 2022 | US$2m | US$583k | -US$55m |
| Sep 30 2022 | n/a | n/a | -US$55m |
| Jun 30 2022 | n/a | n/a | -US$51m |
| Mar 31 2022 | n/a | n/a | -US$48m |
| Dec 31 2021 | US$2m | US$552k | -US$44m |
| Sep 30 2021 | n/a | n/a | -US$37m |
| Jun 30 2021 | n/a | n/a | -US$32m |
| Mar 31 2021 | n/a | n/a | -US$26m |
| Dec 31 2020 | US$4m | US$471k | -US$22m |
| Sep 30 2020 | n/a | n/a | -US$20m |
| Jun 30 2020 | n/a | n/a | -US$18m |
| Mar 31 2020 | n/a | n/a | -US$17m |
| Dec 31 2019 | US$843k | US$388k | -US$17m |
Compensation vs Market: Maria's total compensation ($USD1.79M) is about average for companies of similar size in the US market ($USD2.36M).
Compensation vs Earnings: Maria's compensation has increased whilst the company is unprofitable.
CEO
Maria Palasis (58 yo)
9.3yrs
Tenure
US$1,785,375
Compensation
Dr. Maria Palasis, Ph D, serves as Director at PanTher Therapeutics, Inc. since June 2021. Dr. Palasis has been Chief Executive Officer, President and Director of Lyra Therapeutics, Inc. since January 2015...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 2.2yrs | US$625.06k | 0.44% $ 1.4m | |
| CEO, President & Director | 9.3yrs | US$1.79m | no data | |
| Chief Technology Officer | 1.2yrs | US$1.03m | no data | |
| Co-Founder | no data | no data | no data | |
| CFO, Treasurer & Secretary | 2.6yrs | US$1.07m | no data | |
| Vice President of Operations | no data | no data | no data | |
| Senior Vice President of Investor Relations & Communications | 1.6yrs | no data | no data | |
| Chief Legal Officer | less than a year | no data | no data | |
| Senior Vice President of Commercial Strategy & Market Development | 5.6yrs | US$653.33k | no data | |
| Senior Vice President of Clinical Affairs | no data | no data | no data | |
| Senior Vice President of Technical Operations | 1.2yrs | US$666.79k | no data | |
| Chief Clinical Advisor | 3.2yrs | no data | no data |
2.2yrs
Average Tenure
56.5yo
Average Age
Experienced Management: LYRA's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 2.2yrs | US$625.06k | 0.44% $ 1.4m | |
| CEO, President & Director | 9.3yrs | US$1.79m | no data | |
| Lead Independent Director | 2.1yrs | US$152.31k | 0% $ 0 | |
| Independent Director | 4.4yrs | US$123.81k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.5yrs | US$333.93k | no data | |
| Independent Director | 4.6yrs | US$113.06k | 0.019% $ 61.2k | |
| Member of Scientific Advisory Board | 3.5yrs | US$19.36k | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data |
3.5yrs
Average Tenure
72yo
Average Age
Experienced Board: LYRA's board of directors are considered experienced (3.5 years average tenure).